Aungst BJ[au] - Search Results

Year	Number of Results
1979	1
1981	3
1982	1
1983	1
1985	2
1986	1
1987	1
1988	4
1989	1
1990	7
1991	2
1992	2
1993	1
1995	3
1996	3
1997	4
1998	1
1999	2
2000	4
2001	1
2002	4
2004	1
2005	1
2006	1
2009	1
2011	1
2012	1
2016	1
2017	1
2020	1
2022	0

1

Intestinal permeation enhancers.

Aungst BJ. Aungst BJ. J Pharm Sci. 2000 Apr;89(4):429-42. doi: 10.1002/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J. J Pharm Sci. 2000. PMID: 10737905 Review.

2

Absorption enhancers: applications and advances.

Aungst BJ. Aungst BJ. AAPS J. 2012 Mar;14(1):10-8. doi: 10.1208/s12248-011-9307-4. Epub 2011 Nov 22. AAPS J. 2012. PMID: 22105442 Free PMC article. Review.

3

The Effects of Dose Volume and Excipient Dose on Luminal Concentration and Oral Drug Absorption.

Aungst BJ. Aungst BJ. AAPS J. 2020 Jul 31;22(5):99. doi: 10.1208/s12248-020-00490-9. AAPS J. 2020. PMID: 32737615 Review.

4

Optimizing Oral Bioavailability in Drug Discovery: An Overview of Design and Testing Strategies and Formulation Options.

Aungst BJ. Aungst BJ. J Pharm Sci. 2017 Apr;106(4):921-929. doi: 10.1016/j.xphs.2016.12.002. Epub 2016 Dec 14. J Pharm Sci. 2017. PMID: 27986598 Review.

5

De novo design and discovery of cyclic HIV protease inhibitors capable of displacing the active-site structural water molecule.

De Lucca GV, Jadhav PK, Waltermire RE, Aungst BJ, Erickson-Viitanen S, Lam PY. De Lucca GV, et al. Among authors: aungst bj. Pharm Biotechnol. 1998;11:257-84. doi: 10.1007/0-306-47384-4_12. Pharm Biotechnol. 1998. PMID: 9760684 Review. No abstract available.

6

Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism.

Aungst BJ. Aungst BJ. J Pharm Sci. 1993 Oct;82(10):979-87. J Pharm Sci. 1993. PMID: 8254497 Review.

7

Prodrugs for improved oral beta-estradiol bioavailability.

Hussain MA, Aungst BJ, Shefter E. Hussain MA, et al. Among authors: aungst bj. Pharm Res. 1988 Jan;5(1):44-7. doi: 10.1023/a:1015863412137. Pharm Res. 1988. PMID: 3244608

8

Criteria for selecting pharmacokinetic repeat study samples.

King SP, Aungst BJ, Shen HS. King SP, et al. Among authors: aungst bj. Bioanalysis. 2009 Nov;1(8):1415-8. doi: 10.4155/bio.09.99. Bioanalysis. 2009. PMID: 21083091

9

Intranasal absorption of oxymorphone.

Hussain MA, Aungst BJ. Hussain MA, et al. Among authors: aungst bj. J Pharm Sci. 1997 Aug;86(8):975-6. doi: 10.1021/js960513x. J Pharm Sci. 1997. PMID: 9269879

10

Buccal and oral bioavailability of nalbuphine in rats.

Hussain MA, Aungst BJ, Shefter E. Hussain MA, et al. Among authors: aungst bj. J Pharm Sci. 1986 Feb;75(2):218-9. doi: 10.1002/jps.2600750226. J Pharm Sci. 1986. PMID: 3958937 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results